AVEO Pharmaceuticals' (NASDAQ: AVEO) partner Biodesix, Inc. today announced that its VeriStrat® test is now considered a medically necessary benefit ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE